The risk assessment reports reveal that many of the questions related to MDMB-4en-PINACA and 4F-MDMB-BICA that are posed by the lack of data on the risks to individual health, risks to public health and social risks could be answered through further research. The available information would suggest that the consumption of MDMB-4en-PINACA and 4F-MDMB-BICA causes harm to health associated with their acute toxicity and abuse liability or dependence producing potential. This harm to health is considered life-threatening. There is no specific information on the social risks posed by MDMB-4-en-PINACA and 4F-MDMB-BICA. Therefore, there is sufficient ground for including MDMB-4en-PINACA and 4F-MDMB-BICA in the definition of ‘drug’.
Recital 10, Directive (EU) 2021/802
In forcesince 12 Mar 2021